Fundraising Fox

ivWatch

Newport News, US · Founded 2010 · Virginia LLC

ivWatch makes a continuous IV monitoring system that detects IV infiltrations and extravasations early, alerting clinical teams even when physical signs are not visible. The device is aimed at hospitals and care teams to support patient assessment protocols and reduce negative patient events.

HardwareHealthtechMedical Devices

Founders & leadership

HN
Holly NovakExecutive
GP
Gary P. WarrenExecutive
JZJohn Zwirschitz
John ZwirschitzExecutive
HS
Helen StephensExecutive
JL
Jaclyn LautzExecutive
EWErin Wendell
Erin WendellExecutive
FB
F. Brian Clare Jr.Executive
MF
Melissa FireExecutive
GS
Gregory SchearsExecutive
MG
MICHAEL GAHANExecutive
FB
F. Brian ClareExecutive
CE
Chuck EgressExecutive

Reported raises · per SEC filings

Form D private placements

$90.5M disclosed across 6 rounds · 2014–2024

▶$26.9MraisedSep 2024 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Holly NovakExecutive Officer
  • John R. Lawson IIDirector
  • Gary P. WarrenExecutive Officer, Director
  • Jerrold L. MillerDirector
  • John ZwirschitzExecutive Officer
  • Helen StephensExecutive Officer
  • Michael N. PetkovichDirector
  • Anne ConnerDirector
  • John O. Wynne Jr.Director
  • Jaclyn LautzExecutive Officer, Director
  • Erin WendellExecutive Officer
  • F. Brian Clare Jr.Executive Officer, Director
Offering amount
$33.3M
Amount sold
$26.9M
Proceeds to insiders
$2.4M
First sale
Jan 2024
Incorporated
Limited Liability Company, Virginia
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.5MraisedJan 2024 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary P. WarrenExecutive Officer, Director
  • Jerrold L. MillerDirector
  • Erin WendellExecutive Officer
  • Kathleen CoxExecutive Officer
  • F. Brian Clare Jr.Executive Officer, Director
  • Holly NovakExecutive Officer
  • John O. Wynne Jr.Director
  • Anne ConnerDirector
  • John R. Lawson IIDirector
  • Jaclyn LautzExecutive Officer, Director
  • Helen StephensExecutive Officer
  • Michael N. PetkovichDirector
Offering amount
$17.5M
Amount sold
$17.5M
Proceeds to insiders
$2.5M
First sale
Apr 2023
Incorporated
Limited Liability Company, Virginia
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.7MraisedFeb 2022 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John O. WynneDirector
  • William Jason NaramoreExecutive Officer
  • Gary P. WarrenExecutive Officer, Director
  • Scott AnchellExecutive Officer
  • Jerrold L. MillerDirector
  • Kathleen CarterExecutive Officer
  • Holly NovakExecutive Officer
  • Michael N. PetkovichDirector
  • John R. Gahan Jr.Executive Officer
  • Anne ConnerDirector
  • F. Brian Clare Jr.Executive Officer, Director
  • John R. Lawson IIDirector
  • Matthew AlleyExecutive Officer
  • Erin WendellExecutive Officer
  • Jaclyn LautzExecutive Officer
  • Chuck EgressExecutive Officer
Offering amount
$20M
Amount sold
$13.7M
Proceeds to insiders
$1.9M
First sale
Jun 2020
Incorporated
Limited Liability Company, Virginia
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.9MraisedJan 2020 · 51 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Erin WendellExecutive Officer
  • F. Brian Clare Jr.Executive Officer, Director
  • Holly NovakExecutive Officer
  • Teresa BlevinsExecutive Officer
  • Chuck EgressExecutive Officer
  • Scott AnchellExecutive Officer
  • Matthew AlleyExecutive Officer
  • William Jason NaramoreExecutive Officer
  • Jaclyn LautzExecutive Officer
  • Jerrold L. MillerDirector
  • Gary P. WarrenExecutive Officer, Director
  • Anne ConnerDirector
  • John R. Lawson IIDirector
  • Michael N. PetkovichDirector
  • John O. WynneDirector
  • John R. Gahan Jr.Executive Officer
  • Paul StoddardExecutive Officer
Offering amount
$21M
Amount sold
$18.9M
Proceeds to insiders
$1.9M
First sale
Sep 2017
Incorporated
Limited Liability Company, Virginia
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.8MraisedMar 2017 · 74 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Melissa FireExecutive Officer
  • Gregory SchearsExecutive Officer
  • Jaclyn LautzExecutive Officer
  • MICHAEL GAHANExecutive Officer, Director
  • ANNE CONNERDirector
  • JOHN R. LAWSONDirector
  • F. Brian ClareExecutive Officer, Director
  • Chuck EgressExecutive Officer
  • Leah MooreExecutive Officer
  • MICHAEL N. PETKOVICHDirector
  • Scott AnchellExecutive Officer
  • John O WynneDirector
  • GARY P. WARRENExecutive Officer, Director
  • John GahanExecutive Officer
  • William Jason NaramoreExecutive Officer
Offering amount
$14.5M
Amount sold
$12.8M
Proceeds to insiders
$1.4M
First sale
Sep 2015
Incorporated
Limited Liability Company, Virginia
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$668.7KraisedApr 2014 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • MICHAEL GAHANDirector
  • MICHAEL N. PETKOVICHDirector
  • Javier GarrizExecutive Officer
  • ANNE CONNERDirector
  • Scott AnchellExecutive Officer
  • F. Brian ClareExecutive Officer
  • GARY P. WARRENExecutive Officer, Director
  • JOHN R. LAWSONDirector
  • Gregory J. SchearsExecutive Officer
  • Garret BonnemaExecutive Officer
Offering amount
$5.8M
Amount sold
$668.7K
Proceeds to insiders
$685K
First sale
Mar 2014
Incorporated
Limited Liability Company, Virginia, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Osmosis915 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.

Companies competing with ivWatch for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

ivWatch and Aon Address Costly and Underreported Patient Harm Epidemic with New Return on Investment Modelfinance.yahoo.com · Mar 2026Hampton-based ivWatch receives a $14.8 million funding boost – The Virginian-Pilotpilotonline.com · Jun 2017ivWatch Closes $14.8 Million Funding Round - ivWatchivwatch.com · Jun 2017ivWatch - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does ivWatch do?
ivWatch makes a continuous IV monitoring system that detects IV infiltrations and extravasations early, alerting clinical teams even when physical signs are not visible. The device is aimed at hospitals and care teams to support patient assessment protocols and reduce negative patient events.
How much funding has ivWatch raised?
ivWatch has disclosed $90.5M raised across 6 rounds.
Where is ivWatch headquartered?
ivWatch is headquartered in Newport News, US.